Applying Artificial Intelligence to Address the Knowledge Gaps in Cancer Care.
Autor: | Simon G; Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, Texas, USA., DiNardo CD; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA., Takahashi K; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA., Cascone T; Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, Texas, USA., Powers C; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA., Stevens R; IBM Watson Health, Cambridge, Massachusetts, USA., Allen J; IBM Watson, New York New York, USA., Antonoff MB; Department of Thoracic & Cardiovascular Surgery, MD Anderson Cancer Center, Houston, Texas, USA., Gomez D; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas, USA., Keane P; IBM Watson Health, Cambridge, Massachusetts, USA., Suarez Saiz F; IBM Watson Health, Cambridge, Massachusetts, USA., Nguyen Q; Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, Texas, USA., Roarty E; Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, Texas, USA., Pierce S; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA., Zhang J; Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, Texas, USA., Hardeman Barnhill E; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA., Lakhani K; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA., Shaw K; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, Texas, USA., Smith B; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, Texas, USA., Swisher S; Department of Thoracic & Cardiovascular Surgery, MD Anderson Cancer Center, Houston, Texas, USA., High R; IBM Watson, New York New York, USA., Futreal PA; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, Texas, USA., Heymach J; Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, Texas, USA., Chin L; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, Texas, USA lchin@utsystem.edu. |
---|---|
Jazyk: | angličtina |
Zdroj: | The oncologist [Oncologist] 2019 Jun; Vol. 24 (6), pp. 772-782. Date of Electronic Publication: 2018 Nov 16. |
DOI: | 10.1634/theoncologist.2018-0257 |
Abstrakt: | Background: Rapid advances in science challenge the timely adoption of evidence-based care in community settings. To bridge the gap between what is possible and what is practiced, we researched approaches to developing an artificial intelligence (AI) application that can provide real-time patient-specific decision support. Materials and Methods: The Oncology Expert Advisor (OEA) was designed to simulate peer-to-peer consultation with three core functions: patient history summarization, treatment options recommendation, and management advisory. Machine-learning algorithms were trained to construct a dynamic summary of patients cancer history and to suggest approved therapy or investigative trial options. All patient data used were retrospectively accrued. Ground truth was established for approximately 1,000 unique patients. The full Medline database of more than 23 million published abstracts was used as the literature corpus. Results: OEA's accuracies of searching disparate sources within electronic medical records to extract complex clinical concepts from unstructured text documents varied, with F1 scores of 90%-96% for non-time-dependent concepts (e.g., diagnosis) and F1 scores of 63%-65% for time-dependent concepts (e.g., therapy history timeline). Based on constructed patient profiles, OEA suggests approved therapy options linked to supporting evidence (99.9% recall; 88% precision), and screens for eligible clinical trials on ClinicalTrials.gov (97.9% recall; 96.9% precision). Conclusion: Our results demonstrated technical feasibility of an AI-powered application to construct longitudinal patient profiles in context and to suggest evidence-based treatment and trial options. Our experience highlighted the necessity of collaboration across clinical and AI domains, and the requirement of clinical expertise throughout the process, from design to training to testing. Implications for Practice: Artificial intelligence (AI)-powered digital advisors such as the Oncology Expert Advisor have the potential to augment the capacity and update the knowledge base of practicing oncologists. By constructing dynamic patient profiles from disparate data sources and organizing and vetting vast literature for relevance to a specific patient, such AI applications could empower oncologists to consider all therapy options based on the latest scientific evidence for their patients, and help them spend less time on information "hunting and gathering" and more time with the patients. However, realization of this will require not only AI technology maturation but also active participation and leadership by clincial experts. Competing Interests: Disclosures of potential conflicts of interest may be found at the end of this article. (© AlphaMed Press 2018.) |
Databáze: | MEDLINE |
Externí odkaz: |